Palomino Laboratories (PALX) Cash & Current Investments (2022 - 2025)

Palomino Laboratories has disclosed Cash & Current Investments across 4 years of filings, most recently posting $8.1 million for Q4 2025.

• In Q4 2025, Cash & Current Investments rose 5931.21% year-over-year to $8.1 million; the TTM figure through Dec 2025 stood at $8.1 million (up 5931.21% YoY), while the FY2025 annual figure was $8.1 million, up 5931.21% from the prior year.
• Cash & Current Investments came in at $8.1 million for Q4 2025 at Palomino Laboratories, up from $7.9 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $8.1 million in Q4 2025 to a low of $322.0 in Q2 2024.
• Average Cash & Current Investments over 4 years is $1.5 million, with a median of $500.0 recorded in 2022.
• Year-over-year, Cash & Current Investments declined 24.0% in 2023 and jumped 2452250.62% in 2025.
• Over 4 years, Cash & Current Investments stood at $500.0 in 2022, then decreased by 24.0% to $380.0 in 2023, then surged by 35336.05% to $134657.0 in 2024, then surged by 5931.21% to $8.1 million in 2025.
• Per Business Quant data, the three most recent Cash & Current Investments figures were $8.1 million in Q4 2025, $7.9 million in Q3 2025, and $1887.0 in Q2 2025.